Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Neuroendocrine × durvalumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Lung Neoplasms 12 Colorectal Neoplasms 11 Ovarian Neoplasms 10 Breast Neoplasms 10 Small Cell Lung Carcinoma 8 Urinary Bladder Neoplasms 7 Recurrence 6 Prostatic Neoplasms 6 Neoplasms 6 Head and Neck Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 5 Diabetes Mellitus, Insulin-Dependent, 12 5 Carcinoma, Hepatocellular 5 Carcinoma 5 Neoplasm Metastasis 4 Recurrent Squamous Cell Lung Carcinoma 3 Multiple Myeloma 3 Mouth Neoplasms 3 Mesothelioma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Kidney Neoplasms 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Urothelial Cancer 2

Interventions

Everolimus 5 Bevacizumab 2 veliparib 1 pralsetinib 1 pertuzumab 1 pasireotide 1 carfilzomib 1 cabozantinib 1 berzosertib 1 Topotecan 1 Sunitinib 1 Radiotherapy 1 Radiosurgery 1 Podophyllotoxin 1 Platinum 1 Octreotide 1 Nivolumab 1 Ipilimumab 1 Etoposide 1 Cisplatin 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡